Is Perrigo Company PLC (PRGO) Stock About to Get Hot Thursday?

Overall market sentiment has been neutral on Perrigo Company PLC (PRGO) stock lately. PRGO receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Perrigo Company PLC has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on PRGO!

See Full PRGO Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PRGO Stock Today?

Perrigo Company PLC (PRGO) stock is trading at $32.17 as of 3:37 PM on Thursday, Mar 28, a gain of $0.71, or 2.26% from the previous closing price of $31.46. The stock has traded between $31.48 and $32.31 so far today. Volume today is less active than usual. So far 794,896 shares have traded compared to average volume of 2,752,368 shares.

More About Perrigo Company PLC

Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma. Click Here to get the full Stock Report for Perrigo Company PLC stock.